(VIANEWS) – Shares of PCI BIOTECH HOLD (Oslo Børs All-share Index_GI: PCIB.OL) dropped by a staggering 11.17% to kr2.67 at 13:39 EST on Monday, after three successive sessions in a row of gains. Oslo Børs All-share Index_GI is rising 0.04% to kr1,403.08, after five consecutive sessions in a row of losses. This seems, up to now, a somewhat positive trend trading session today.
PCI BIOTECH HOLD’s last close was kr3.00, 49.66% under its 52-week high of kr5.96.
About PCI BIOTECH HOLD
PCI Biotech Holding ASA, a biopharmaceutical company, focuses on the development and commercialization of novel therapies for the treatment of cancer through its photochemical internalization (PCI) technology platform. The company develops anticancer paradigms, including fimaCHEM, a chemotherapeutics for treatment of cancer; fimaVACC, a T-cell induction technology for therapeutic vaccination, which is in Phase I clinical study; and fimaNAc, a nucleic acid therapeutics delivery technology, which is in pre-clinical study. It also offers Amphinex, a photosensitiser fimaporfin. The company has collaborative research programs with Bavarian Nordic, BioNTech, Phio Pharmaceuticals, DCprime, eTheRNA immunotherapies, IMV, and Aposense. PCI Biotech Holding ASA is based in Oslo, Norway.
Earnings Per Share
As for profitability, PCI BIOTECH HOLD has a trailing twelve months EPS of kr-1.937.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -64.36%.
Moving Average
PCI BIOTECH HOLD’s worth is way above its 50-day moving average of kr2.41 and below its 200-day moving average of kr2.94.
Yearly Top and Bottom Value
PCI BIOTECH HOLD’s stock is valued at kr2.67 at 13:39 EST, way below its 52-week high of kr5.96 and way higher than its 52-week low of kr1.52.
Volatility
PCI BIOTECH HOLD’s last week, last month’s, and last quarter’s current intraday variation average was a positive 7.35%, a negative 0.30%, and a positive 7.39%.
PCI BIOTECH HOLD’s highest amplitude of average volatility was 11.51% (last week), 8.46% (last month), and 7.39% (last quarter).
More news about PCI BIOTECH HOLD (PCIB.OL).
